• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.具有高水平同源中和活性的猿猴免疫缺陷病毒(SIV)包膜特异性Fab片段:从长期不进展的SIV感染猕猴中获得
J Virol. 1998 Jan;72(1):585-92. doi: 10.1128/JVI.72.1.585-592.1998.
2
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.对源自感染减毒猴免疫缺陷病毒(SIV)毒株的恒河猴的恒河猴单克隆抗体所识别的SIV中和表位的鉴定。
Virology. 2001 Nov 10;290(1):59-73. doi: 10.1006/viro.2001.1144.
3
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.1型和2型人类免疫缺陷病毒以及猿猴免疫缺陷病毒分离株的交叉中和作用
J Virol. 1992 Jun;66(6):3602-8. doi: 10.1128/JVI.66.6.3602-3608.1992.
4
Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.天然序列变异对单克隆抗体识别的影响可中和猿猴免疫缺陷病毒的感染性。
J Virol. 1994 Sep;68(9):5395-402. doi: 10.1128/JVI.68.9.5395-5402.1994.
5
Antigenic variation of SIV: mutations in V4 alter the neutralization profile.猴免疫缺陷病毒的抗原变异:V4区的突变改变中和特性。
Virology. 1996 Jul 1;221(1):14-21. doi: 10.1006/viro.1996.0348.
6
Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.用减毒的嗜巨噬细胞猴免疫缺陷病毒免疫恒河猴诱导产生的交叉保护性免疫反应。
J Virol. 1995 May;69(5):2737-44. doi: 10.1128/JVI.69.5.2737-2744.1995.
7
Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.用寡聚猿猴免疫缺陷病毒包膜蛋白免疫产生的中和单克隆抗体的特性鉴定与表位作图
J Virol. 2000 Sep;74(17):7922-35. doi: 10.1128/jvi.74.17.7922-7935.2000.
8
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.猴免疫缺陷病毒V3环作为抗体介导中和作用靶点的能力:中和敏感性、在巨噬细胞中的生长以及对CD4依赖性降低之间的相关性
J Virol. 2001 Apr;75(8):3903-15. doi: 10.1128/JVI.75.8.3903-3915.2001.
9
Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus.嵌合猕猴/人源Fab分子可中和猴免疫缺陷病毒。
Virology. 1995 Mar 10;207(2):495-502. doi: 10.1006/viro.1995.1109.
10
Isolation of potent neutralizing monoclonal antibodies from an SIV-Infected rhesus macaque by phage display.通过噬菌体展示从感染SIV的恒河猴中分离高效中和单克隆抗体。
AIDS Res Hum Retroviruses. 2011 May;27(5):487-500. doi: 10.1089/AID.2010.0191. Epub 2010 Nov 23.

引用本文的文献

1
Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies.一类广泛中和性丙型肝炎病毒抗E2 VH1-69抗体的筛选与鉴定
PLoS Pathog. 2025 Mar 28;21(3):e1012428. doi: 10.1371/journal.ppat.1012428. eCollection 2025 Mar.
2
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants.强效单克隆抗体可中和奥密克戎亚谱系及其他 SARS-CoV-2 变体。
Cell Rep. 2022 Nov 1;41(5):111528. doi: 10.1016/j.celrep.2022.111528. Epub 2022 Sep 30.
3
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.通过噬菌体展示技术开发用于诊断和治疗的针对传染病和毒素的重组抗体。
Front Cell Infect Microbiol. 2021 Jul 7;11:697876. doi: 10.3389/fcimb.2021.697876. eCollection 2021.
4
Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.用于诊断和治疗的重组抗体,针对通过噬菌体展示产生的病原体和毒素。
Proteomics Clin Appl. 2016 Oct;10(9-10):922-948. doi: 10.1002/prca.201600002. Epub 2016 Jun 21.
5
Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells.从恒河猴单个抗体分泌细胞高效生成单克隆抗体。
MAbs. 2015;7(4):707-18. doi: 10.1080/19420862.2015.1051440.
6
Intramuscular injection of AAV8 in mice and macaques is associated with substantial hepatic targeting and transgene expression.在小鼠和猕猴中进行肌肉注射AAV8与显著的肝脏靶向性和转基因表达相关。
PLoS One. 2014 Nov 13;9(11):e112268. doi: 10.1371/journal.pone.0112268. eCollection 2014.
7
Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus.腺相关病毒9介导的抗体气道表达可保护老龄和免疫缺陷小鼠免受流感病毒感染。
Clin Vaccine Immunol. 2014 Nov;21(11):1528-33. doi: 10.1128/CVI.00572-14. Epub 2014 Sep 10.
8
Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses.由 V3 和 V4 环组成的构象表位,作为针对灵长类免疫缺陷病毒的有效和广泛中和的靶点。
J Virol. 2013 May;87(10):5424-36. doi: 10.1128/JVI.00201-13. Epub 2013 Mar 6.
9
Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus.结构洞察抗登革病毒的高等灵长类抗体的中和机制。
EMBO J. 2012 Feb 1;31(3):767-79. doi: 10.1038/emboj.2011.439. Epub 2011 Dec 2.
10
Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys.感染猕猴 SIVmac251 后,自体中和抗体针对传播/原始病毒的出现较晚。
J Virol. 2010 Jun;84(12):6018-32. doi: 10.1128/JVI.02741-09. Epub 2010 Mar 31.

本文引用的文献

1
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.人源单克隆抗体对人免疫缺陷病毒1型原始分离株JR-FL的中和作用与抗体和包膜糖蛋白复合物寡聚体形式的结合相关。
J Virol. 1997 Apr;71(4):2779-85. doi: 10.1128/JVI.71.4.2779-2785.1997.
2
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3.一种分子克隆的致病性、中和抗性猿猴免疫缺陷病毒,SIVsmE543-3。
J Virol. 1997 Feb;71(2):1608-20. doi: 10.1128/JVI.71.2.1608-1620.1997.
3
Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.在SIV/猕猴模型中的被动免疫球蛋白治疗:早期干预可改变疾病状况。
Immunol Lett. 1996 Jun;51(1-2):107-14. doi: 10.1016/0165-2478(96)02563-1.
4
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding.人类对克隆于噬菌体展示文库中的1型人类免疫缺陷病毒糖蛋白41的抗体反应表明,有三个主要表位被识别,并为抗原结合中保守的抗体基序提供了证据。
AIDS Res Hum Retroviruses. 1996 Jul 1;12(10):911-24. doi: 10.1089/aid.1996.12.911.
5
Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection.对怀孕猕猴进行疫苗接种可保护新生猕猴免受黏膜型猿猴免疫缺陷病毒感染。
J Infect Dis. 1996 Jun;173(6):1327-35. doi: 10.1093/infdis/173.6.1327.
6
Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.V3特异性抗体在涉及1型人类免疫缺陷病毒原始毒株和实验室适应毒株的中和试验中的不同作用。
AIDS Res Hum Retroviruses. 1995 Nov;11(11):1379-91. doi: 10.1089/aid.1995.11.1379.
7
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.急性感染恒河猴中猿猴免疫缺陷病毒特异性CD8 +淋巴细胞反应
J Virol. 1993 Mar;67(3):1707-11. doi: 10.1128/JVI.67.3.1707-1711.1993.
8
Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex.1型人类免疫缺陷病毒的包膜糖蛋白gp120改变星形胶质细胞中的离子转运:对艾滋病痴呆综合征的影响。
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):494-8. doi: 10.1073/pnas.91.2.494.
9
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.1型人类免疫缺陷病毒原发性综合征中细胞免疫反应与病毒血症初始控制的时间关联。
J Virol. 1994 Jul;68(7):4650-5. doi: 10.1128/JVI.68.7.4650-4655.1994.
10
Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251.用免疫血清或一组中和单克隆抗体对食蟹猴进行被动免疫,未能使其免受SIVmac251攻击的保护。
AIDS Res Hum Retroviruses. 1994 Feb;10(2):189-94. doi: 10.1089/aid.1994.10.189.

具有高水平同源中和活性的猿猴免疫缺陷病毒(SIV)包膜特异性Fab片段:从长期不进展的SIV感染猕猴中获得

Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.

作者信息

Glamann J, Burton D R, Parren P W, Ditzel H J, Kent K A, Arnold C, Montefiori D, Hirsch V M

机构信息

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA.

出版信息

J Virol. 1998 Jan;72(1):585-92. doi: 10.1128/JVI.72.1.585-592.1998.

DOI:10.1128/JVI.72.1.585-592.1998
PMID:9420262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC109411/
Abstract

An antibody phage display library was constructed from RNA extracted from lymph node cells of a simian immunodeficiency virus (SIV)-infected long-term-nonprogressor macaque. Seven gp120-reactive Fabs were obtained by selection of the library against SIV monomeric gp120. Although each of the Fabs was unique in sequence, there were two distinct groups based on epitope recognition, neutralizing activity in vitro, and molecular analysis. Group 1 Fabs did not neutralize SIV and bound to a linear epitope in the V3 loop of the SIV envelope. In contrast, two of the group 2 Fabs neutralized homologous, neutralization-sensitive SIVsm isolates with high efficiency but failed to neutralize heterologous SIVmac isolates. Based on competition enzyme-linked immunosorbent assays with mouse monoclonal antibodies of known specificity, these Fabs reacted with a conformational epitope that includes domains V3 and V4 of the SIV envelope. These neutralizing and nonneutralizing Fabs provide valuable standardized and renewable reagents for studying the role of antibody in preventing or modifying SIV infection in vivo.

摘要

从一只感染了猴免疫缺陷病毒(SIV)的长期不进展猕猴的淋巴结细胞中提取RNA,构建了一个抗体噬菌体展示文库。通过针对SIV单体gp120筛选该文库,获得了7个与gp120反应的Fab片段。尽管每个Fab片段在序列上都是独特的,但根据表位识别、体外中和活性和分子分析可分为两个不同的组。第1组Fab片段不能中和SIV,且与SIV包膜V3环中的线性表位结合。相比之下,第2组中的两个Fab片段能高效中和同源的、中和敏感的SIVsm分离株,但不能中和异源的SIVmac分离株。基于与已知特异性的小鼠单克隆抗体进行的竞争酶联免疫吸附试验,这些Fab片段与一个构象表位反应,该表位包括SIV包膜的V3和V4结构域。这些中和及非中和Fab片段为研究抗体在体内预防或改变SIV感染中的作用提供了有价值的标准化和可再生试剂。